Consensus Fractyl Health, Inc.

Equities

GUTS

US35168W1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
6.1 ^USD	-1.45%		-3.79%	0.00%

May. 13	Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000	MT
May. 13	Fractyl Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Fractyl Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d04b87dedd5870522fffdf13e700a2ef.37kLPwMZ6BePGWdBjuxcXrNhFBQ6aUisNSdiEJrxvZo.jthkRnRqjmfpVF8m-r8GO4VMdyBqJgvgdh8bVtG2x_KN7X5lZi2hQsdjEA~0d38c179bb5ba715693be233fe1c0357

Analyst Recommendations on Fractyl Health, Inc.

Evercore ISI Initiates Fractyl Health at Outperform Rating	Feb. 28	MT
BofA Securities Initiates Fractyl Health at Buy Rating With $26 Price Target	Feb. 27	MT
Morgan Stanley Initiates Fractyl Health at Overweight Rating With $18 Price Target	Feb. 27	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.1 USD

Average target price

22 USD

Spread / Average Target

+260.66%

High Price Target

26 USD

Spread / Highest target

+326.23%

Low Price Target

18 USD

Spread / Lowest Target

+195.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fractyl Health, Inc.

Evercore ISI
BofA Securities
Morgan Stanley

Annual profits - Rate of surprise

Company calendar